Mustea A - Search Results

1

Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense?

Woelber L, Bommert M, Prieske K, Fischer I, Zu Eulenburg C, Vettorazzi E, Harter P, Jueckstock J, Hilpert F, de Gregorio N, Iborra S, Sehouli J, Ignatov A, Hillemanns P, Fuerst S, Strauss HG, Baumann K, Beckmann M, Mustea A, Meier W, Wimberger P, Hanker L, Canzler U, Fehm T, Luyten A, Hellriegel M, Kosse J, Heiss C, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Mahner S, Schmalfeldt B, Jaeger A. Woelber L, et al. Among authors: mustea a. Geburtshilfe Frauenheilkd. 2020 Dec;80(12):1221-1228. doi: 10.1055/a-1120-0138. Epub 2020 Dec 3. Geburtshilfe Frauenheilkd. 2020. PMID: 33293730 Free PMC article.

2

Interleukin-1 receptor antagonist gene polymorphism and cancer.

Sehouli J, Mustea A. Sehouli J, et al. Among authors: mustea a. Clin Infect Dis. 2002 Jun 1;34(11):1535-6. doi: 10.1086/340530. Clin Infect Dis. 2002. PMID: 12015703 No abstract available.

3

Polymorphism of IL-1 receptor antagonist gene: role in cancer.

Sehouli J, Mustea A, Könsgen D, Katsares I, Lichtenegger W. Sehouli J, et al. Among authors: mustea a. Anticancer Res. 2002 Nov-Dec;22(6A):3421-4. Anticancer Res. 2002. PMID: 12530098 Review.

4

Preoperative determination of CASA (Cancer Associated Serum Antigen) and CA-125 for the discrimination between benign and malignant pelvic tumor mass: a prospective study.

Sehouli J, Akdogan Z, Heinze T, Könsgen D, Stengel D, Mustea A, Lichtenegger W. Sehouli J, et al. Among authors: mustea a. Anticancer Res. 2003 Mar-Apr;23(2A):1115-8. Anticancer Res. 2003. PMID: 12820357

5

Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer.

Sehouli J, Mustea A, Koensgen D, Lichtenegger W. Sehouli J, et al. Among authors: mustea a. Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1205-8. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14652282

6

Prognostic significance of epithelial cells in the blood of patients with gynaecological malignancies.

Sehouli J, Könsgen D, Nimpsch R, Stengel D, Oskay G, Mustea A, Oertel J, Lichtenegger W. Sehouli J, et al. Among authors: mustea a. Anticancer Res. 2003 Sep-Oct;23(5b):4133-40. Anticancer Res. 2003. PMID: 14666614

7

Altered expression pattern of topoisomerase IIalpha in ovarian tumor epithelial and stromal cells after platinum-based chemotherapy.

Chekerov R, Klaman I, Zafrakas M, Könsgen D, Mustea A, Petschke B, Lichtenegger W, Sehouli J, Dahl E. Chekerov R, et al. Among authors: mustea a. Neoplasia. 2006 Jan;8(1):38-45. doi: 10.1593/neo.05580. Neoplasia. 2006. PMID: 16533424 Free PMC article.

8

Expression of IL-10 in patients with ovarian carcinoma.

Mustea A, Könsgen D, Braicu EI, Pirvulescu C, Sun P, Sofroni D, Lichtenegger W, Sehouli J. Mustea A, et al. Anticancer Res. 2006 Mar-Apr;26(2C):1715-8. Anticancer Res. 2006. PMID: 16617566 Free article.

9

Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.

Koensgen D, Mustea A, Klaman I, Sun P, Zafrakas M, Lichtenegger W, Denkert C, Dahl E, Sehouli J. Koensgen D, et al. Among authors: mustea a. Gynecol Oncol. 2007 Nov;107(2):266-73. doi: 10.1016/j.ygyno.2007.06.023. Epub 2007 Aug 14. Gynecol Oncol. 2007. PMID: 17698176

10

New aspects of adjuvant therapy in endometrial cancer: current standards and future directions.

Sehouli J, Koensgen D, Oskay-Ozcelik G, Mustea A. Sehouli J, et al. Among authors: mustea a. Crit Rev Oncol Hematol. 2008 Sep;67(3):204-12. doi: 10.1016/j.critrevonc.2008.02.011. Epub 2008 Apr 14. Crit Rev Oncol Hematol. 2008. PMID: 18407513 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page